Yldzdaş Dinçer, Yapcoǧlu Hacer, Ylmaz Hayri Levent
*Faculty of Medicine, Pediatric Intensive Care Unit, Çukurova University, Adana, Turkey; †Faculty of Medicine, Division of Neonatology, Department of Pediatrics, Çukurova University, Adana, Turkey; ‡Faculty of Medicine, Department of Pediatric Emergency Medicine, Çukurova University, Adana, Turkey.
Pediatr Emerg Care. 2004 Mar;20(3):162-165. doi: 10.1097/01.pec.0000117922.65522.26.
To measure changes in end-tidal carbon dioxide levels (ETco2) with different sedation/analgesia (midazolam, ketamine, ketamine plus midazolam, midazolam plus fentanyl, and propofol) during pediatric minor surgical procedures and to determine whether there were significant increases in ETco2 with different drugs.
We conducted a prospective, randomized, clinical trial of 126 children who needed sedation/analgesia in pediatric intensive care unit in a university hospital. Patients were randomly assigned to 1 of 5 treatment groups. Group K received only intravenous (IV) ketamine 1 mg/kg; group M, IV midazolam 0.15 mg/kg; group KM, IV ketamine 1 mg/kg plus IV midazolam 0.1 mg/kg; group MF, IV midazolam 0.1 mg/kg plus IV fentanyl 2 microg/kg; and group P, IV propofol 2 mg/kg. Side stream, nasal cannula ETco2 tracings were recorded on a capnograph (Capnostat, Marquette). Recordings began prior to the administration of medications and continued throughout the procedure until the patient was fully awake. The primary outcome variable was the difference between peak ETco2 before and during sedation/analgesia. This value was determined by scanning the records for the peak ETco2 averaged over 5 breaths before and after the administration of medications.
There was neither any statistical difference between presedation/analgesia and postsedation/analgesia ETco2 levels in the 5 groups (P > 0.05) nor any difference in the first 3 groups between presedation/analgesia, sedation/analgesia, and postsedation/analgesia (K, M, and KM) (P > 0.05). In the midazolam plus fentanyl and propofol groups, mean ETco2 during sedation/analgesia was higher than the mean ETco2 during presedation/analgesia and postsedation/analgesia (P < 0.05). Twenty-one patients (16, 6%) had respiratory depression [hypercarbia (ETco2 > 50 mm Hg) or hypoxia (oxygen saturation > 90% for over 1 minute)], 21 patients (16, 6%) had hypercarbia, and 4 patients (3.2%) had both hypoxia and hypercarbia. One of 4 patients was in the MF group, and 3 were in the P group. Two subjects (8%) in the KM group, 7 (28%) in the MF group, and 13 (52%) in the P group had hypercarbia.
This study demonstrated that propofol and midazolam-fentanyl produced a higher incidence of respiratory depression and higher mean ETco2 during sedation/analgesia than presedation and postsedation/analgesia. Capnography can serve as a useful monitoring tool in the evaluation of ventilation during sedation or sedation/analgesia in clinically stable children.
测量小儿小手术过程中使用不同镇静/镇痛药物(咪达唑仑、氯胺酮、氯胺酮加咪达唑仑、咪达唑仑加芬太尼和丙泊酚)时呼气末二氧化碳水平(ETco2)的变化,并确定不同药物使用时ETco2是否有显著升高。
我们在一家大学医院的儿科重症监护病房对126名需要镇静/镇痛的儿童进行了一项前瞻性、随机临床试验。患者被随机分配到5个治疗组中的1组。K组仅静脉注射氯胺酮1mg/kg;M组静脉注射咪达唑仑0.15mg/kg;KM组静脉注射氯胺酮1mg/kg加静脉注射咪达唑仑0.1mg/kg;MF组静脉注射咪达唑仑0.1mg/kg加静脉注射芬太尼2μg/kg;P组静脉注射丙泊酚2mg/kg。使用旁流鼻导管在二氧化碳监测仪(Capnostat,Marquette)上记录ETco2曲线。记录在给药前开始,并在整个手术过程中持续,直到患者完全清醒。主要结局变量是镇静/镇痛前和镇静/镇痛期间的ETco2峰值之差。该值通过扫描给药前后5次呼吸平均的ETco2峰值记录来确定。
5组患者镇静/镇痛前和镇静/镇痛后ETco2水平之间均无统计学差异(P>0.05),前3组(K、M和KM)在镇静/镇痛前、镇静/镇痛期间和镇静/镇痛后也无差异(P>0.05)。在咪达唑仑加芬太尼组和丙泊酚组中,镇静/镇痛期间的平均ETco2高于镇静/镇痛前和镇静/镇痛后的平均ETco2(P<0.05)。21名患者(16.6%)出现呼吸抑制[高碳酸血症(ETco2>50mmHg)或低氧血症(氧饱和度<90%超过1分钟)],21名患者(16.6%)出现高碳酸血症,4名患者(3.2%)同时出现低氧血症和高碳酸血症。4名患者中有1名在MF组,3名在P组。KM组中有2名受试者(8%)、MF组中有7名(约28%)、P组中有13名(52%)出现高碳酸血症。
本研究表明,与镇静/镇痛前和镇静/镇痛后相比,丙泊酚和咪达唑仑-芬太尼在镇静/镇痛期间导致呼吸抑制的发生率更高,平均ETco2更高。二氧化碳监测在评估临床稳定儿童的镇静或镇静/镇痛期间的通气情况时可作为一种有用的监测工具。